Quaternary ammonium silane k21 based intracanal medicament triggers biofilm destruction

by Kirk Kimmerling | May 7, 2021 | Related Article

Quaternary ammonium silane (k21) based intracanal medicament triggers biofilm destruction

Download

FiteBac is a biotech company dedicated to making the world a safer place with our antimicrobial technology.

CONTACT

Contact Us

Zoom Meeting

DOCUMENTS

SDS File FiteBac Antimicrobial Cavity Cleanser

510K Summary FiteBac Antimicrobial Cavity Cleanser

Certificate of Medical Device Master File (MAF)

FiteBac Cavity Cleanser IFU

LEGAL

Privacy Policy

NDA Form

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.